About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Managing High Risk/Relapsed Follicular Lymphoma
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Nathan H. Fowler
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Nathan H. Fowler
0 views
October 25, 2018
Comments
0
Login to view comments.
Click here to Login
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Recommended
AUTOPLAY
ON
Related
Newest
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
06:33
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
17:07
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…
Feat.
M. Minnema
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
19:46
Scripps Health
Management of Indolent NHL
Feat.
E. Brem
37:44
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
Feat.
M. Kamdar
08:28
Bruce D. Cheson
Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS
19:20
Mitchell Smith
Treatment Landscape in Follicular Lymphoma
25:23
Indy Hematology Review
When Not to Watch and Wait: Emerging Strategies in the Treatment of …
Feat.
M. Williams
08:58
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…
Feat.
C. Flowers
19:14
SOHO Brazil 2024
FL: How Do I Deal With Relapse?
Feat.
B. Kahl
26:58
Total Health
Update on Cellular Therapy in Lymphoma
Feat.
B. Randolph
22:38
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…
Feat.
T. Phillips
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current Clinical Management of Follicular Lymphoma
Feat.
B. Ferhanoğlu
14:34
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
Feat.
L. Gordon
10:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…
Feat.
R. Merryman
16:34
Jennifer Amengual
Top 5 Lymphoma Abstracts From ASH
